World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
46918
World Ranking
15847
National Ranking
7976

Overview

Jordan Berlin is affiliated with Vanderbilt University Medical Center in the United States. Their research primarily spans the fields of medicine and biochemistry, genetics, and molecular biology, with a significant focus on oncology and related subfields.

Their published work emphasizes topics including colorectal cancer treatments and studies, pancreatic and hepatic oncology research, and cancer genomics and diagnostics. Additional research interests cover lung cancer treatments and mutations, neuroendocrine tumor research advances, gastric cancer management and outcomes, as well as cancer immunotherapy and biomarkers.

Notable recent papers authored or co-authored by Jordan Berlin include:

  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials, 2020, published in The Lancet Oncology
  • Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial, 2021, published in Annals of Oncology
  • Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update, 2021, published in Journal of Clinical Oncology
  • The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022, published in ESMO Open
  • Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial, 2022, published in Journal of Clinical Oncology

The scientist frequently collaborates with peers such as Satya Das, Dana B. Cardin, Kristen K. Ciombor, David S. Hong, and Alexander Drilon, with whom they have co-authored numerous publications.

Their work is frequently published in venues including the Journal of Clinical Oncology, Annals of Oncology, Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, The Oncologist, and Cancer Research.

Best Publications

  • BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER

    Herbert Hurwitz;Louis Fehrenbacher;William Novotny;Thomas Cartwright

  • Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

    Jonathan Strosberg;G. El-Haddad;Edward Wolin;A. Hendifar

  • Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children

    Alexander Drilon;Theodore W. Laetsch;Shivaani Kummar;Steven G. DuBois

  • The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

    Luis A. Diaz;Luis A. Diaz;Richard T. Williams;Jian Wu;Jian Wu;Isaac Kinde

  • Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

    Christine H. Chung;Beloo Mirakhur;Emily Chan;Quynh Thu Le

  • Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

    Jordan D. Berlin;Paul Catalano;James P. Thomas;John W. Kugler

  • Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

    Herbert I. Hurwitz;Louis Fehrenbacher;John D. Hainsworth;William Heim

  • Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

    Mace L. Rothenberg;Amit M. Oza;Robert H. Bigelow;Jordan D. Berlin

  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

    David S Hong;Steven G DuBois;Shivaani Kummar;Anna F Farago

  • Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

    Frank A. Scappaticci;Louis Fehrenbacher;Thomas Cartwright;John D. Hainsworth

  • Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum

    Mary Kay Washington;Jordan Berlin;Philip Branton;Lawrence J. Burgart

  • Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

    Elizabeth Poplin;Yang Feng;Jordan Berlin;Mace L. Rothenberg

  • American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes

    Lee M. Ellis;David S. Bernstein;Emile E. Voest;Jordan D. Berlin

  • Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.

    Aditya Bardia;Ingrid A. Mayer;Jennifer R. Diamond;Rebecca L. Moroose

  • Diagnosis and Treatment of Cholangiocarcinoma

    Christopher D. Anderson;C. Wright Pinson;Jordan Berlin;Ravi S. Chari

  • Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study

    Mark Kozloff;Marianne Ulcickas Yood;Jordan Berlin;Patrick J. Flynn

  • Neuroendocrine tumors, version 1.2015

    Matthew H. Kulke;Manisha H. Shah;Al B. Benson;Emily Bergsland

  • Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Alok A. Khorana;Pamela B. Mangu;Jordan Berlin;Anitra Engebretson

  • Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models.

    Michael L Schulte;Allie Fu;Ping Zhao;Jun Li

  • NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

    Clark Oh;Benson Ab rd;Berlin Jd;Choti Ma

Frequent Co-Authors

Al B. Benson
Al B. Benson Northwestern University
Wells A. Messersmith
Wells A. Messersmith University of Colorado Boulder
Philip A. Philip
Philip A. Philip Wayne State University
David M. Goldenberg
David M. Goldenberg Immunomedics (United States)
David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center
Robert M. Sharkey
Robert M. Sharkey University of Fukui
Eileen M. O’Reilly
Eileen M. O’Reilly Memorial Sloan Kettering Cancer Center
Howard S. Hochster
Howard S. Hochster Yale University
Aditya Bardia
Aditya Bardia Harvard University
Robert J. Coffey
Robert J. Coffey Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative routes in healthcare can help individuals find the right career fit and accelerate their professional journey. For example, those interested in advanced nursing roles may consider the easiest DNP programs, which offer flexible online options for experienced nurses to earn a Doctor of Nursing Practice and move into leadership positions.

If you’re seeking a faster entry into nursing, fastest LPN program pathways enable students to qualify as Licensed Practical Nurses in less time, often with online and hybrid learning for greater convenience. Similarly, the fastest PMHNP program options allow registered nurses to quickly specialize as Psychiatric Mental Health Nurse Practitioners, a field in high demand.

Apart from clinical roles, leadership and administrative positions are critical in healthcare. Pursuing an online Master of Health Administration is a practical path for those interested in managing medical facilities, policies, or systems. Each of these online programs opens new career doors and offers flexible solutions to meet educational and professional goals in medicine and healthcare.

Best Scientists Citing Jordan Berlin

Trending Scientists

Recently Published Articles